Form 8-K - Current report:
SEC Accession No. 0001104659-21-032713
Filing Date
2021-03-05
Accepted
2021-03-05 16:05:04
Documents
3
Period of Report
2021-03-05
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm218851d1_8k.htm 8-K 17878
2 EXHIBIT 99.1 tm218851d1_ex99-1.htm EX-99.1 7398
3 GRAPHIC logo.jpg GRAPHIC 3827
  Complete submission text file 0001104659-21-032713.txt   31951
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Filer) CIK: 0001279704 (see all company filings)

EIN.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36598 | Film No.: 21718491
SIC: 2834 Pharmaceutical Preparations